The University of Chicago Header Logo

Connection

Philip Charles Hoffman to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Philip Charles Hoffman has written about Drug Resistance, Neoplasm.
Philip Charles Hoffman
Connection Strength
0.176
Drug Resistance, Neoplasm
  1. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.157
  2. Personalized treatment of lung cancer. Semin Oncol. 2011 Apr; 38(2):274-83.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.